| Mayur Chandrakant Patel, MD | |
|
775 Poplar Rd, Suite 130, Newnan, GA 30265-8300 | |
| (770) 683-6921 | |
| Not Available |
| Full Name | Mayur Chandrakant Patel |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 26 Years |
| Location | 775 Poplar Rd, Newnan, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164603676 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 069418 (Georgia) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 069418 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Newnan Hospital, Inc | Newnan, GA | Hospital |
| Piedmont Hospital | Atlanta, GA | Hospital |
| Piedmont Fayette Hospital | Fayetteville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Providers Llc | 9830082825 | 371 |
| Piedmont Specialty Hospital Billing Llc | 4183986490 | 179 |
News Archive
The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell.
New research in the December issue of Preventive Medicine, published by Elsevier, shows that there was a decline in access to cigarettes from commercial venues from 2000 to 2003.
Myriad Pharmaceuticals, Inc. today announced several strategic initiatives to focus the Company's efforts on its oncology pipeline and to conserve its financial resources to extend the Company's projected cash runway beyond 2013.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
A research team from the University of Valencia, led by Professor Juan Saus from the Department of Biochemistry and Molecular Biology, is developing a project to provide the healthcare system with a diagnostic test that anticipates the entry into advanced stages of patients with COVID-19 and a scalable oral treatment for the disease.
› Verified 5 days ago
| Entity Name | Piedmont Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548273592 PECOS PAC ID: 9830082825 Enrollment ID: O20040204000321 |
News Archive
The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell.
New research in the December issue of Preventive Medicine, published by Elsevier, shows that there was a decline in access to cigarettes from commercial venues from 2000 to 2003.
Myriad Pharmaceuticals, Inc. today announced several strategic initiatives to focus the Company's efforts on its oncology pipeline and to conserve its financial resources to extend the Company's projected cash runway beyond 2013.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
A research team from the University of Valencia, led by Professor Juan Saus from the Department of Biochemistry and Molecular Biology, is developing a project to provide the healthcare system with a diagnostic test that anticipates the entry into advanced stages of patients with COVID-19 and a scalable oral treatment for the disease.
› Verified 5 days ago
| Entity Name | Piedmont Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376624940 PECOS PAC ID: 3274529524 Enrollment ID: O20040423000767 |
News Archive
The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell.
New research in the December issue of Preventive Medicine, published by Elsevier, shows that there was a decline in access to cigarettes from commercial venues from 2000 to 2003.
Myriad Pharmaceuticals, Inc. today announced several strategic initiatives to focus the Company's efforts on its oncology pipeline and to conserve its financial resources to extend the Company's projected cash runway beyond 2013.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
A research team from the University of Valencia, led by Professor Juan Saus from the Department of Biochemistry and Molecular Biology, is developing a project to provide the healthcare system with a diagnostic test that anticipates the entry into advanced stages of patients with COVID-19 and a scalable oral treatment for the disease.
› Verified 5 days ago
| Entity Name | Piedmont Specialty Hospital Billing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699290510 PECOS PAC ID: 4183986490 Enrollment ID: O20180327001180 |
News Archive
The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell.
New research in the December issue of Preventive Medicine, published by Elsevier, shows that there was a decline in access to cigarettes from commercial venues from 2000 to 2003.
Myriad Pharmaceuticals, Inc. today announced several strategic initiatives to focus the Company's efforts on its oncology pipeline and to conserve its financial resources to extend the Company's projected cash runway beyond 2013.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
A research team from the University of Valencia, led by Professor Juan Saus from the Department of Biochemistry and Molecular Biology, is developing a project to provide the healthcare system with a diagnostic test that anticipates the entry into advanced stages of patients with COVID-19 and a scalable oral treatment for the disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mayur Chandrakant Patel, MD 775 Poplar Rd, Suite 130, Newnan, GA 30265-8300 Ph: () - | Mayur Chandrakant Patel, MD 775 Poplar Rd, Suite 130, Newnan, GA 30265-8300 Ph: (770) 683-6921 |
News Archive
The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell.
New research in the December issue of Preventive Medicine, published by Elsevier, shows that there was a decline in access to cigarettes from commercial venues from 2000 to 2003.
Myriad Pharmaceuticals, Inc. today announced several strategic initiatives to focus the Company's efforts on its oncology pipeline and to conserve its financial resources to extend the Company's projected cash runway beyond 2013.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
A research team from the University of Valencia, led by Professor Juan Saus from the Department of Biochemistry and Molecular Biology, is developing a project to provide the healthcare system with a diagnostic test that anticipates the entry into advanced stages of patients with COVID-19 and a scalable oral treatment for the disease.
› Verified 5 days ago
Mrs. Linda C Cunanan, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 109 Bullsboro Dr, Newnan, GA 30263 Phone: 770-251-4140 Fax: 770-251-7275 | |
Dr. Ashish Dhungel, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1425 Highway 34 E, Newnan, GA 30265 Phone: 770-304-3724 | |
Nitika Sharma, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 600 Celebrate Life Pkwy, Newnan, GA 30265 Phone: 770-400-6000 | |
James M. Smith, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 Newnan Crossing Blvd E, Suite 200, Newnan, GA 30265 Phone: 770-400-7700 | |
Ayesha Afsar Faruqi, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 Newnan Crossing Blvd E, Suite 200, Newnan, GA 30265 Phone: 770-400-7700 | |
Dr. Samer Bedi Blackmon, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1825 Highway 34 E, St. 3000, Newnan, GA 30265 Phone: 770-252-6767 Fax: 404-564-5902 | |
Gargi Schneider, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 745 Poplar Rd, Newnan, GA 30265 Phone: 404-367-3014 |